GlassScriptPhysician profile
Robert Evan Anderson
NPI 1023126562
$959.74
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $476 · 2020: $60.36 · 2021: $204 · 2022: $169 · 2023: $30.34 · 2024: $20.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $50.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $50.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $286.56 | 2019-2021 | |
| Organon LLC | $230.39 | 2021-2022 | |
| Emd Serono, INC. | $183.09 | 2019-2024 | |
| Ferring Pharmaceuticals INC. | $170.42 | 2019 | |
| Vertical Pharmaceuticals, LLC | $35.01 | 2019 | |
| Bard Peripheral Vascular, INC. | $29.96 | 2022 | |
| Abbott Laboratories | $24.31 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.